MULTAQ: payments to doctors
Payments that named MULTAQ as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.6M
- Providers
- 12,532
- Transactions
- 56,804
- Average per transaction
- $64
The per-transaction average — $64 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12,532 providers the average total is $289, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi-aventis U.S. LLC | $3,603,705 | 99.6% |
| Sanofi | $8,263 | 0.2% |
| Sanofi US Services Inc. | $7,582 | 0.2% |